Maheshwari Pharmaceuticals (India) Limited - Company Profile

It is a healthcare public limited company based in Delhi, Delhi, India, established in 2002.
2002 Delhi, Delhi, India Active
Last Updated:
Access Report
About Maheshwari Pharmaceuticals (India) Limited

Maheshwari Pharmaceuticals (India) Limited, a active public limited company, was established on 19 February 2002 in Delhi, Delhi, India. Engaging in ayurvedic products & services within the manufacturing sector, it holds CIN: U24231DL2002PLC114280. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹8.60 M.

It upholds a compliant status. Employing 167 professional, Its leadership includes Tarun Maheshwari (Director), Rajinder Prasad Maheswari (Managing Director), Deepak Maheshwari (Director). Past directors included Pramod Maheshwari, Sanjeev Maheshwari, Deepak Maheshwari. It holds ₹28.41 Cr open charges and ₹1.76 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at B-65, Swasth Vihar, Vikas Marg,, Delhi, Delhi, 110092.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231DL2002PLC114280

  • Registration Number

    114280

  • Incorporation Date

    19 February 2002

  • Authorized Capital

    ₹1.00 Cr

  • Paid-Up Capital

    ₹8.60 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 Cr
  • Paid Up Capital ₹ 8.60 M
  • Company Age 24 Year, 6 Days
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 28.41 Cr
  • Satisfied Charges ₹ 1.76 Cr
  • Revenue Growth **** 9.02%
  • Profit Growth **** 24.54%
  • Ebitda **** 29.05%
  • Net Worth 10.51%
  • Total Assets **** 5.46%
Company report

Maheshwari Pharmaceuticals (India) Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Maheshwari Pharmaceuticals (India) Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Maheshwari Pharmaceuticals (India) Limited?
Current Directors
Name Designation Appointment Date Status
Tarun Maheshwari Director 19 Feb 2002 Current
Rajinder Prasad Maheswari Managing Director 19 Feb 2002 Current
Deepak Maheshwari Director 14 May 2014 Current
Nikhil Maheshwari Director 01 Mar 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 14 May 2014 Past
Pramod Abcsdd Director 13 Mar 2014 Past
Pramod Abcsdd Additional Director 29 Sep 2014 Past
Pramod Abcsdd Additional Director 29 Sep 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Maheshwari Pharmaceuticals (India).

Maheshwari Pharmaceuticals (India) Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 9.02% increase. The company also saw a substantial improvement in profitability, with a 24.54% increase in profit. The company's net worth Soared by an impressive increase of 10.51%.

Maheshwari Pharmaceuticals (India) revenue growth over time
Maheshwari Pharmaceuticals (India) profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 9.02%
*******
*******
*******
*******
Revenue from Operations
*******
 8.95%
*******
*******
*******
*******
Total Assets
*******
 5.46%
*******
*******
*******
*******
Profit or Loss
*******
 24.54%
*******
*******
*******
*******
Net Worth
*******
 10.51%
*******
*******
*******
*******
EBITDA
*******
 29.05%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Maheshwari Pharmaceuticals (India)?

In 2024, Maheshwari Pharmaceuticals (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹284,086,011.00

Satisfied Charges

₹17,600,000.00

Charges Breakdown by Lending Institutions
  • Others : 11.54 Cr
  • Hdfc Bank Limited : 11.24 Cr
  • Corporation Bank : 5.62 Cr
Latest Charge Details
Date Lender Amount Status
27 Aug 2024 Hdfc Bank Limited ₹3.02 M Open
16 Jan 2024 Hdfc Bank Limited ₹1.40 M Open
29 Jul 2022 Hdfc Bank Limited ₹0.62 M Open
18 Sep 2018 Hdfc Bank Limited ₹10.74 Cr Open
15 Sep 2015 Others ₹7.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Maheshwari Pharmaceuticals (India)?

Maheshwari Pharmaceuticals (India) has a workforce of 167 employees as of Mar 25, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Maheshwari Pharmaceuticals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maheshwari Pharmaceuticals (India)'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Maheshwari Pharmaceuticals (India)
Recent Activity within the Organization
  • Charges

    Progress on A charge with Others of Rs. 4.54 Cr registered on 08 Jul 2014 with Charge ID 10509065 was modified on 29 Oct 2025. was documented.

  • Annual General Meeting

    The activity Maheshwari Pharmaceuticals (India) Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.

  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.30 Cr with Charge ID 100972486 was registered on 27 Aug 2024. was documented.

  • Balance Sheet

    The activity Maheshwari Pharmaceuticals (India) Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.

  • Director Appointment

    Progress on Nikhil Maheshwari was appointed as a Director was appointed as a Director on 01 Mar 2024 & has been associated with this company since 1 year 11 months . was documented.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 0.14 Cr with Charge ID 100882650 was registered on 16 Jan 2024. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Maheshwari Pharmaceuticals (India) Limited?

The CIN of Maheshwari Pharmaceuticals (India) Limited is U24231DL2002PLC114280.

Where is Maheshwari Pharmaceuticals (India) Limited headquartered?

Maheshwari Pharmaceuticals (India) Limited is headquartered at B-65, Swasth Vihar, Vikas Marg,, Delhi, Delhi, 110092.

When was Maheshwari Pharmaceuticals (India) Limited incorporated?

Maheshwari Pharmaceuticals (India) Limited was incorporated on 19 February 2002.

Who are the current directors of Maheshwari Pharmaceuticals (India) Limited?

The current directors of Maheshwari Pharmaceuticals (India) Limited are

What is the primary industry of Maheshwari Pharmaceuticals (India) Limited?

The primary industry of Maheshwari Pharmaceuticals (India) Limited is Manufacturing.

Is Maheshwari Pharmaceuticals (India) Limited a listed company?

Maheshwari Pharmaceuticals (India) Limited is unlisted.

What is the capital structure of Maheshwari Pharmaceuticals (India) Limited?

The authorized capital of Maheshwari Pharmaceuticals (India) Limited is ₹1.00 Cr, and the paid-up capital is ₹8.60 M.

What is the compliance status of Maheshwari Pharmaceuticals (India) Limited?

The compliance status of Maheshwari Pharmaceuticals (India) Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available